Log In
Tuesday 11th December 2018


FT Health

US drugmaker Gilead poaches Roche executive Daniel O’Day

Pharmaceuticals chief will replace John Milligan who announced his departure in July

Akorn tumbles after US court upholds ruling on Fresenius deal cancellation

Fresenius set for worst fall in 20 years after profit warning

EU warns of disease risk as vaccination rates fall

Trend partly driven by populist political movements, says health commissioner

DeepMind in AI breakthrough with smarter version of AlphaGo

AlphaZero plays Go and chess at levels that defeat humans and the best existing programs

Actelion Pharmaceuticals agrees to pay $360m in DoJ settlement

Takeda/haemophilia: blood test

If gene therapy lives up to its promise, it will justify the song and dance

Takeda wins shareholder approval for £46bn Shire deal

Vote paves way for Japan’s largest ever corporate takeover

Flexibility on cancer drugs approval is essential

It now takes more than a year longer than in the 2000s for medicines to reach patients

GSK buys Tesaro for $5.1bn to boost cancer drugs

Shares lose 7 per cent on news of drugmaker’s first big acquisition under Emma Walmsley

UN climate change summit, Takeda investors vote on Shire acquisition

The FT's Daniel Garrahan previews some of the big stories in the week ahead

UK to unveil £1bn life sciences investment

Government keen to show Britain remains attractive despite Brexit

Mastering evolution: the first gene-edited babies

Scientists have the tools to permanently alter human DNA, but some fear genetic meddling could have unintended consequences

IC — Pennon, Greggs, Thomas Cook

Companies analysis from our sister publication

British home care group saved by last-ditch sale

Allied Healthcare bought after regulator warns of possible bankruptcy

FT Health: Climate change and the threat to health

Barry Rassin on polio, nutrition and hunger, scorpion-milking robots

Nimble biotechs become vital partners for large pharma groups

Need to find innovative medicines fuels new collaborations for UK small-caps

Bayer to cut 12,000 jobs and sell non-core businesses

German group seeks to regain investor confidence following legal setbacks

The scorpion-milking robot: extracting the poison that cures

Scorpion venom can be used to help detect and cure diseases

A modest proposal for the Open Data Institute

Geospatial data, big tech and the specter of monopoly.

Moderna/biotech: cure all

Company’s plan for an IPO would be better served by ensuring its medicines work

South Korea legalises medical marijuana

Bayer/Loxo: gene machine

New cancer drug promises to become a blockbuster but there are big hurdles to overcome

Cancer or climate change: which cure would you invest in?

Chances of making money with a sugar pill are greater than a carbon capture plan

Private equity puts £100m price tag on foster care agency

Sovereign Capital seeks to dispose of Partnerships in Children’s Services

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018